Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00570180
What this trial is testing

Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 36
Testing effectiveness (Phase 2)UnknownNCT00438841
What this trial is testing

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT06103838
What this trial is testing

18F-Fluciclovine PET/CT in Multiple Myeloma

Who this might be right for
Multiple MyelomaNewly Diagnosed Multiple Myeloma (NDMM)Relapsed and/or Refractory Multiple Myeloma (RRMM)
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT03602755
What this trial is testing

The First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

Who this might be right for
Multiple Myeloma
Celgene 706
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06799676
What this trial is testing

A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma

Who this might be right for
Newly Diagnosed Multiple Myeloma
Fuling Zhou 42
Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing

JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 276
Testing effectiveness (Phase 2)Study completedNCT00396045
What this trial is testing

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Turin, Italy 54
Not applicableLooking for participantsNCT07087964
What this trial is testing

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma (NDMM)
Universiteit Antwerpen 120
Not applicableUnknownNCT05088330
What this trial is testing

Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM

Who this might be right for
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University 76
Testing effectiveness (Phase 2)Looking for participantsNCT07053436
What this trial is testing

Horizon Two: HR NDMM (MMRC-100)

Who this might be right for
High Risk Newly Diagnosed Multiple Myeloma
Multiple Myeloma Research Consortium 300
Post-approval studies (Phase 4)Study completedNCT04217967
What this trial is testing

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 211
Testing effectiveness (Phase 2)Active Not RecruitingNCT04786028
What this trial is testing

Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

Who this might be right for
Multiple Myeloma
Canadian Myeloma Research Group 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830485
What this trial is testing

CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 24
Testing effectiveness (Phase 2)WithdrawnNCT06348147
What this trial is testing

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Who this might be right for
Newly Diagnosed Multiple MyelomaMultiple MyelomaAutologous Stem Cell Transplantation
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01857115
What this trial is testing

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 63
Not applicableStudy completedNCT00898066
What this trial is testing

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous/Nonmalignant Condition
SWOG Cancer Research Network 37
Testing effectiveness (Phase 2)Ended earlyNCT02897830
What this trial is testing

Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Large-scale testing (Phase 3)UnknownNCT02248428
What this trial is testing

Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Jinling Hospital, China 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687004
What this trial is testing

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)Study completedNCT00057564
What this trial is testing

Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene Corporation 470
Next Page